moksha8 awarded Best Practices Award for Excellence in Market Penetration in Latin America by Frost & Sullivan

In a very short period of time moksha8 has positioned itself as an important pharmaceutical company in Latin America, with an unique strategy. The evidence of sales and efficiency leverage is demonstrated in the growth of product sales since Moksha8 assumed commercialization responsibility of some mature products from Roche and Pfizer. There has been consistent and sustained performance as a direct result of our commercial strategies.

The high quality operations in Brazil and Mexico and the strong track record of success, give Moksha8 a solid platform to expand product offering and operations in both countries with additional partnerships and introducing new products into these markets.

There are some specific key strengths that helped moksha8 to be more competitive and visible in the Brazil and Mexico pharmaceutical markets. The company employs a highly trained field force of specialized sales representative who visit a very targeted group of physicians. The marketing and promotional information is customized for these physicians and the sales representatives visit a higher number of physicians, hospitals and pharmacies on a weekly basis to ensure broad coverage Secondly, Moksha8's leadership (CEO, General Managers and other Executive Management) frequently spends time in the field and provide educational events for physicians. Moksha8's management is highly visible with customers. Lastly, the competitive strength is strongly dependent on quality. The company prioritizes quality in everything, from communications to sales and marketing and customer service.